Future Pharma: How digital transformation will revolutionise our time-to-market

Developing new drugs is expensive and time-consuming, yet, digital manufacturing techniques are delivering significant benefits without compromising on quality, as Eric Flynn, Head of Pharmaceuticals and Life Sciences at Siemens GB&I explains.